Patent on Ingenus Pharma cancer-fighting injection is invalid, US judge finds
Recitation of a “stable” formulation of the anti-cancer injectable cyclophosphamide doomed an Ingenus Pharmaceuticals patent on Friday, with the term deemed indefinite. In the same decision, a US judge in Illinois...To view the full article, register now.
Already a subscriber? Click here to view full article